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Introduction	
	 Type	2	Diabetes	prevalence	is	increasing	worldwide.	According	to	the	WHO	2016	Report	on	Diabetes,	from	1980	to	2014	the	total	estimated	number	of	people	with	diabetes	increased	from	108	to	422	million	(1).		The	prevalence	of	diabetes	nearly	doubled	during	this	time	period-	increasing	from	4.7	to	8.5%	of	the	world’s	population	(1).	Although	previous	research	deemed	diabetes	a	disease	of	developed	nations,	new	studies	demonstrate	this	is	no	longer	the	case.	The	WHO	reported	that	diabetes	prevalence	has	increased	faster	in	lower	and	middle	income	countries,	and	that	the	Southeast	Asia	and	Western	Pacific	regions	are	accountable	for	half	of	the	diabetes	cases	in	the	world	(1).		Diabetes	is	not	only	more	prevalent	in	these	regions-	it	is	also	increasing	in	its	deadliness.	The	WHO	estimates	that	from	1980	to	2014,	the	western	Pacific	experienced	the	largest	rise	in	deaths	attributable	to	high	blood	glucose	(1).	Apart	from	its	impact	on	life	expectancy,	the	complications	associated	with	diabetes,	such	as	kidney	failure,	blindness	and	heart	disease	serve	to	negatively	impact	the	economic	productivity	of	individuals,	thereby	affecting	societies	as	a	whole	(2).		Understanding	the	causes	and	risks	associated	with	type	2	diabetes	onset	is	imperative	in	engineering	better	prevention	and	intervention	methods	that	will	decrease	diabetes	prevalence	and	mitigate	its	harmful	complications.	A	variety	of	factors	have	been	identified	and	are	widely	accepted	as	risk	factors	for	type	2	diabetes,	including	obesity,	physical	inactivity	and	family	history	(2).	The	study	of	depression	as	a	novel	risk	factor	for	type	2	diabetes	has	been	a	point	of	interest	in	a	growing	body	of	research,	which	has	found	that	depressive	symptoms	are	associated	with	an	increased	risk	for	type	2	diabetes	(3).			Studying	depression	as	a	risk	factor	for	type	2	diabetes	is	crucial	because	depression	is	becoming	increasingly	prevalent	worldwide.	According	to	the	WHO	Global	Burden	of	Diseases	2004	Update,	depression	is	the	third	leading	cause	of	disability,	with	an	estimated	98.7	million	individuals	affected	worldwide	(4).	In	2004,	depression	was	the	leading	cause	of	years	lost	to	disability	(YLDs)	in	both	males	and	females,	although	for	females	the	burden	was	50%	higher	(4).	Previous	
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assumptions	that	depression	is	limited	to	the	developed	world	are	incorrect.	The	WHO	reports	that	unipolar	depressive	disorders	account	for	55.3	million	YLDs	in	lower	and	middle-income	countries,	and	only	for	10.0	YLDs	in	high-income	countries	(4).	The	body	of	evidence	supporting	an	association	between	depression	and	type	2	diabetes	onset	is	increasing.	Research	supports	a	bi-directional	relationship	between	the	two	illnesses	(3).	A	meta	analysis	of	this	relationship	found	that	depression	is	associated	with	a	60%	increased	risk	of	developing	type	2	diabetes;	a	modest	increased	risk	was	noted	when	type	2	diabetes	was	used	as	a	predictor	of	depression	onset	(3).	However,	this	meta-analysis	was	based	on	13	studies	that	relied	on	self-reports,	and	not	formalized	diagnostic	criteria.		Other	studies	have	used	a	retrospective	cohort	design	to	assess	relative	risk	based	on	depression	status.		In	a	cohort	of	4,803	Spanish	older	adults,	it	was	found	that	clinically	significant	depression	was	associated	with	65%	increased	risk	of	diabetes	mellitus	(5).	This	study	used	a	standardized	method	to	measure	depression,	the	Geriatric	Mental	State	Schedule,	and	AGECAT	criteria	(diagnostic	for	depression	in	older	adults).	However,	the	study	population	was	limited	to	a	high-income	country	(Spain).	Other	studies	that	have	used	standardized	measures	to	quantify	depressive	symptoms	have	also	found	an	increased	risk	of	type	2	diabetes	associated	with	depression;	but	their	populations	have	also	been	limited	to	high-income	countries	(6–11).	As	both	depression	and	type	2	diabetes	are	becoming	recognized	problems	beyond	the	developed	world,	it	is	imperative	that	more	research	be	focused	on	the	populations	of	low	and	middle-income	countries.	An	understanding	of	depression	and	its	comorbidities	could	have	considerable	implications	for	the	health	of	such	populations.	The	Cebu	Longitudinal	Health	and	Nutrition	Survey	(CLHNS)	provides	a	unique	opportunity	to	test	for	an	association	between	depressive	symptoms	and	type	2	diabetes	incidence	in	the	less	studied	setting	of	a	middle	income	country.	The	large	sample	size	and	robust	longitudinal	data	allow	for	establishment	of	temporality	and	a	sequential	analysis	of	the	two	illnesses.	The	survey	measured	
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depressive	symptoms	and	type	2	diabetes	using	standardized	measures	in	a	large	cohort	of	middle	to	older	aged	Filipino	women,	followed	from	2005-2012.	Since	both	depression	and	diabetes	were	measured	using	standardized	measures	(CES-D	derived	depression	scale	and	blood	glucose/HbA1c),	the	cohort	allows	for	precision	that	has	not	been	consistently	possible	in	other	previous	studies.	We	conducted	prospective	analysis	of	depressive	symptoms	in	2005	as	predictors	of	type	2	diabetes	incidence	in	2012.	Because	the	survey	included	measurements	of	socioeconomic	factors,	weight,	adiposity,	education,	we	were	able	to	explore	these	factors	as	possible	confounders.		
Methods		
Study	Population	The	cohort	was	selected	using	a	cluster	sampling	method;	33	communities	or	barangays	(17	urban,	16	rural)	from	the	Metropolitan	Cebu	area	were	randomly	selected	for	the	baseline	survey	in	late	1982	and	again	in	early	1983.	All	women	who	gave	birth	from	May	1,	1983	to	April	30,	1984	were	included	in	the	initial	sample;	3,327	women	were	enrolled.	The	women	were	followed	for	two	years	postpartum	and	follow	up	surveys	were	conducted	in	1991-92,	1994-95,	1998-99,	2002,	2005,	2007,	and	2012.	Biomarkers	were	added	to	the	CLHNS	in	2005.	Informed	consent	was	obtained	from	all	CLHNS	subjects,	and	the	University	of	North	Carolina	Institutional	Review	Board	for	the	Protection	of	Human	Subjects	approved	the	study	protocol.		
Exposure	Depression	symptoms	were	measured	using	a	survey	based	on	the	WHO	recommended	20-item	Center	for	Epidemiological	Studies	Depression	Scale	(CES-D)(12).		The	local	research	team	discarded	certain	questions	and	added	ones	that	were	deemed	more	culturally	appropriate	(13).	The	survey	consisted	of	16	questions,	each	asking	how	often	the	respondent	experienced	a	certain	symptom	(difficulty	falling	asleep,	feeling	lonely,	etc.)	during	the	past	4	weeks.	Possible	
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responses	were	none	of	the	time	(1),	occasionally	(2),	and	most	of	the	time	(3).	12	items	were	dichotomized,	with	0=	none	of	the	time	and	1=occasionally	or	most	of	the	time	(figure	1).	Then,	an	index	score	was	created	by	summing	the	12	variables.	The	index	showed	a	high	degree	of	reliability	(Cronbach	α=0.80)	(14).	The	12	item	score	was	used	for	consistency	with	prior	work	in	the	Cebu	study	(14).	We	analyzed	depression	scores	and	depression	change	scores	from	2005	to	2012,	to	see	if	a	change	in	depression	was	also	a	significant	predictor	of	incident	type	2	diabetes.	Change	score	was	calculated	as	depression	score	in	2012	minus	depression	score	in	2005.	A	negative	score	indicates	a	decrease	in	depressive	symptoms	from	2005	to	2012.	All	variables	were	standardized	using	Z	scores	for	easier	interpretation	and	were	analyzed	as	continuous	variables.	
Figure	1:	Items	used	in	depression	score	
How	frequently	in	the	past	4	weeks	did	you	experience	these	common	
feelings	or	problems?	You	had	headaches?	You	had	poor	digestion?	You	were	worried?	You	felt	lonely?	You	felt	people	disliked	you?	You	had	difficulty	falling	asleep?	People	were	unfriendly?	You	felt	you	couldn’t	overcome	difficulties?	You	thought	of	yourself	as	worthless?	You	felt	life	isn’t	worth	living?	You	wished	you	were	dead?	You	had	the	idea	of	taking	your	own	life?	
Footnote:	Response	options	were	none	of	the	time,	occasionally,	and	most	of	the	time.  
Outcome	In	2005,	Individuals	were	classified	as	having	type	2	diabetes	if	they	listed	“type	2	diabetes”	when	asked	“Did	you	have	any	of	the	following	illnesses	since	2002	(or	last	visit)?”,	or	if	they	had	a	fasting	blood	glucose	greater	than	or	equal	to	126	mg/dl.	A	fasting	blood	sample	was	obtained	by	the	research	team	at	the	homes	of	participants.	The	fasting	venous	whole-blood	sample	was	analyzed	using	a	
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glucometer	(OneTouch,	Johnson	&	Johnson	Ltd.)(15).	To	approximate	plasma	glucose,	a	correction	factor	of	0.97	mmol/L	(17.5	mg/dL)	was	subtracted	from	the	venous	blood	glucose	values	(16).	In	2012,	individuals	were	classified	as	having	type	2	diabetes	using	the	same	survey	question	as	in	2005,	or	if	they	had	an	HbA1c	greater	than	or	equal	to	6.5%	(NycoCard®	READER	II).	In	both	2005	and	2012,	participants	were	asked	to	list	all	medications	they	were	taking	at	the	time.	Responses	were	categorized	into	the	MIMS	classification	index,	and	respondents	reporting	use	of	Insulin	preparations	(MIMS	index	1101)	or	Antidiabetic	agents	(MIMS	index	1102)	were	classified	as	having	diabetes.	A	three	level	diabetes	incidence	variable	was	generated	and	used	as	the	main	outcome	variable.	Participants	were	classified	as	either	never	having	diabetes	if	they	had	no	diabetes	in	2005	or	2012	(0),	having	chronic	diabetes	if	they	were	diabetic	in	both	2005	and	2012,	and	having	incident	diabetes	if	they	were	not	diabetic	in	2005,	but	were	diabetic	in	2012.	Those	who	were	classified	diabetic	in	2005	and	non-diabetic	in	2012	were	excluded	from	the	analysis.		
Covariates	Waist	circumference	was	measured	three	times	using	a	plastic	measuring	tape	to	the	nearest	centimeter	about	two	inches	above	the	navel	(17).	The	mean	of	the	three	measurements	was	used	as	a	continuous	variable.	Height	(cm)	and	weight	(kg)	were	measured	using	a	portable	stadiometer	and	scale,	respectively,	using	standard	techniques	(17).	Education	was	measured	as	years	of	schooling,	and	was	categorized	as	no	completion	of	primary	school	(1),	completion	of	primary	but	not	high	school	(2),	and	high	school	graduate	or	more	(3).	Because	of	its	non-linear	association	with	the	outcome	variable,	age	was	categorized	into	three	groups	based	on	trends	(Table	1).		Urbanicity	was	measured	as	a	continuous,	community	level	variable.	The	scale	used	allows	for	a	more	nuanced	analysis	of	the	ways	that	living	environment	impacts	health.	The	variable	was	constructed	using	7	components:	population	size;	population	density;	communications	(availability	of	mail,	telephone,	internet,	cable	
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TV,	and	newspaper	services);	transportation	(paved	road	density	and	public	transportation	services);	markets	(presence	of	gas	stations,	drug	stores,	grocery	stores,	and	the	number	of	small	commercial	kiosks);	educational	facilities;	and	health	services.	Each	component	response	ranged	from	1-10,	giving	a	total	variable	range	of	0-70.	The	urbanicity	variable	measures	a	latent	quality	imperfectly	captured	by	each	of	these	components	independently,	and	is	an	estimation	of	economic	development.	Higher	urbanicity	scores	are	associated	with	more	urban	barangays,	while	lower	scores	are	associated	with	more	rural	barangays.	(18).		A	continuous	household	assets	variable	was	used	to	approximate	respondents’	socioeconomic	statuses.	The	assets	score	was	created	using	principle	factor	analysis,	including	a	comprehensive	list	of	household	possessions.	
	
Statistical	Analysis	By	2005,	1,309	respondents	were	lost	to	follow	up	giving	a	sample	size	of	2,018.	By	2012,	the	cohort	size	was	1,815.	For	this	study,	we	limited	our	analysis	to	women	with	complete	depressive	symptoms	and	biomarker	data	from	2005	and	2012.	In	2005,	1	respondent	did	not	complete	the	depression	questions,	131	respondents	did	not	give	blood	samples	for	fasting	glucose,	and	205	did	not	answer	the	diabetes	self	report	section	of	the	questionnaire.	This	resulted	in	a	2005	sample	of	1,887.	In	2012,	43	respondents	refused	the	HbA1c	test,	1	had	too	low	hemoglobin,	and	for	17	the	test	was	not	administered-	as	a	result,	the	final	2012	sample	size	was	1,811.	The	final	sample	size	for	our	analysis	was	1,651.	(Table	1).	Participants	lost	to	follow	up	were	more	likely	to	have	higher	income,	more	education,	and	live	in	more	urban	settings,	and	assumed	to	have	a	high	degree	of	(economic)	mobility.	Participants	who	were	lost	to	follow	up	due	to	death	were	more	likely	to	be	of	lower	income.	Other	work	using	the	CLHNS	has	not	found	evidence	of	significant	attrition	bias	(19).	
Table	1:	Comparison	of	Study	Sample	and	Baseline	Sample	Characteristics	
Variable	 Baseline	Sample	 Study	Sample	 Pr(|T|>|t|)	
Assets	score	 2.609*	 2.380*	 0.0006	
Value	of	Household	 11808.61	 10393.85	 0.3696	
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Assets	
Total	Household	
income	
306.234*	 260.021*	 0.0115	
Highest	grade	of	
schooling	
completed	
7.469*	 6.777*	 0.0000	
Urbanicity	score	 32.553*	 28.871*	 0.0000	
Age	(years)	 25.951	 26.121	 0.4140	
Footnote:	 Two-sample	 t	 test	 for	 means	 was	 used	 to	 analyze	 differences,	 and	 the	 2-tailed	 p-value	 is	
displayed.	Starred	values	are	significantly	different	with	95%	confidence.	Models	were	estimated,	using	multinomial	logistic	regression	in	Stata	14(20).	In	the	first	model,	the	non-diabetic	group	(group	0)	was	the	referent,	and	the	likelihood	of	being	in	the	chronic	or	incident	diabetes	groups	vs	the	healthy	was	estimated,	controlling	for	age,	urbanicity,	assets,	and	education.	Waist	circumference	and	BMI	were	also	controlled	for	in	alternate	analyses	in	order	to	account	for	their	different	associations	with	type	2	diabetes	risks.		The	second	model	estimates	the	likelihood	of	incident	vs	chronic	diabetes,	using	the	latter	as	the	referent	group.	This	second	analysis	was	done	in	order	to	compare	the	risk	differences	of	prevalent	and	incident	diabetes.	
	
Results	
Participant	Characteristics	Characteristics	of	participants	in	2005	are	summarized	by	outcome	group	in	Table	2.	The	mean	depression	score	of	the	sample	in	2005	was	17.20	±	3.32,	and	remained	approximately	the	same	in	2012,	as	indicated	by	the	mean	change	score	close	to	zero	(-0.20	±	3.84).	Type	2	diabetes	prevalence	increased	from	9.38%	in	2005	to	16.99%	in	2012.		
Table	2:	General	Characteristics	in	2005	by	2012	diabetes	status	(n=1,655)	
2005	 Nondiabetic	 Prevalent	Diabetic	
Incident	
Diabetic	
Total	
Number	of	women	 1,392	
(84.11%)	
112	(7.37%)	 151	(9.12%)	 1,655	
Depression	Score	(mean	
±	sd)	
Change	in	Depression	
	
17.23	±	3.35	
	
	
17.37	±	3.24	
	
	
16.94	±	3.21	
	
	
17.20	±	3.32	
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Score	(mean)	 -0.25	±	3.83	 0.43	±	4.10	 0.38	±	3.85	 -0.20	±	3.84	
Age	
mean	
ranges:	
35-40	
40-50	
50+	
	
48.16	±	6.01	
	
67	(85.90%)	
851	(85.19%)	
474	(82.01%)	
	
49.11	±	5.83	
	
6	(7.69%)	
56	(5.61%)	
50	(8.65%)	
	
48.54	±	5.49	
	
5	(6.41%)	
92	(9.21%)	
54	(9.34%)	
	
48.27	±	5.95	
	
78	
999	
578	
Education	
Mean	years	
Did	not	complete	primary		
Completed	primary,	but	
not	high	school	
High	school	graduate	or	
more	
	
6.92	±	3.51	
491	(88.79%)	
639	(85.54%)	
	
262	(73.80%)	
	
8.60	±	3.99	
27	(4.88%)	
46	(6.61%)	
	
39	(10.99%)	
	
8.60	±	4.26	
35	(6.33%)	
62	(8.30%)	
	
54	(15.21%)	
	
7.17	±	3.66	
553	
747	
	
355	
Assets	Score	 6.47	±	5.63	 9.12	±	7.02	 9.34	±	7.27	 6.91	±	5.97	
Urban	index	 39.66	±	14.01	 44.79	±	
10.90	
44.19	±	
11.81	
40.20	±	
13.69	
Body	Mass	Index	(mean	±	
sd	
23.96	±	4.18	 26.35	±	4.23	 26.11	±	4.69	 24.33	±	4.30	
Waist	Circumference	
(mean	±	sd)	
79.87	±	10.29	 88.62	±	9.82	 85.49	±	
11.43	
81.01	±	
10.69		
Depressive	Symptoms	and	Diabetes	Incidence	Depressive	symptoms	were	positively	associated	with	increased	risk	of	type	2	diabetes	prevalence	(Table	3).	When	compared	with	the	nondiabetic	group,	for	every	standard	deviation	away	from	the	mean	depressive	score,	the	likelihood	of	diabetes	prevalence	increased	by	35.7%	(p=0.010)	with	waist	circumference,	and	by	41.9%	(p=0.003)	with	BMI.		For	every	positive	change	in	depression	score	from	2005	to	2012,	there	was	a	42.5	(p=0.003)	increased	likelihood	of	diabetes	prevalence	with	waist	circumference,	and	a	41.6%	(p=0.003)	increased	likelihood	of	diabetes	prevalence	with	BMI.	No	significant	association	was	found	between	depressive	symptoms	or	change	in	depressive	symptoms	and	diabetes	incidence	in	either	model.		
Table	3	Panel	a:	Relative	Risk	Ratio	(Prevalent	versus	nondiabetic,	n=1,651)	
		 Model	1	(Waist	Circumference)	 Model	2	(BMI)		 RRR	 95%	 P- RRR	 Interval	 P-Value	
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Confidence	
Interval	
Value	
Standardized	
Depression	
Score	
1.357	 (1.075,	1.713)	 0.010	 1.419	 (1.127,	1.786)	 0.003	
Standardized	
Change	Score	
1.425	 (1.132,	1.794)	 0.003	 1.416	 (1.128,	1.778)	 0.003	Age	2	3	 	0.604	1.017	 	(0.243,	1.500)	(0.405,	2.553)	 	0.278	0.971	 	0.625	1.220	 	(0.253,	1.543)	(0.480,	2.989)	 	0.308	0.671	Education	2	3	 	1.177	1.778	 	(0.695,	1.994)	(0.960,	3.259)	 	0.544	0.063	 	1.184	1.817	 	(0.702,	1.996)	(0.995,	3.317)	 	0.758	0.052	Urbanicity	 1.019	 (1.000,	1.037)	 0.045	 1.021	 (1.003,	1.040)	 0.021	Assets	F1	 	1.034	 	(0.100,	1.069)	 	0.134	 	1.038	 	(1.004,	1.073)	 	0.029	Waist/BMI	 1.070	 (1.050,	1.091)	 0.000	 1.122	 (1.072,	1.175)	 0.000	
	
Table	3	Panel	b:	Relative	Risk	Ratio	(Incident	versus	nondiabetic,	n=1,651)	
		 Model	1	(Waist	Circumference)	 Model	2	(BMI)		 RRR	 95%	
Confidence	
Interval	
P-
Value	
RRR	 Interval	 P-Value	
Standardized	
Depression	
Score	
0.969	 (0.781,	1.203)	 0.778	 0.996	 (0.801,	1.237)	 0.968	
Standardized	
Change	Score	
0.952	 (0.765,	1.186)	 0.663	 0.943	 (0.757,	1.174)	 0.599	Age	2	3	 	1.273	1.355	 	(0.490,	3.305)	(0.511,	3.588)	 	0.620	0.542	 	1.303	1.524	 	(0.502,	3.380)	(0.575,	4.038)	 	0.587	0.397	Education	2	3	 	1.183	1.912	 	(0.753,	1.860)	(1.133,	3.225)	 	0.759	0.015	 	1.187	1.946	 	(0.756,	1.865)	(1.154,	3.282)	 	0.457	0.013	Urbanicity	 0.995	 (0.981,	1.008)	 0.440	 0.995	 (0.982,	1.009)	 0.521	Assets	F1	 	1.040	 	(0.010,	1.070)	 	0.008	 	1.039	 	(1.009,	1.069)	 	0.010	Waist/BMI	 1.046	 (1.029,	1.064)	 0.000	 1.107	 (1.0632,	1.153)	 0.000		 We	also	analyzed	the	likelihood	of	incident	type	2	diabetes	in	comparison	to	prevalent	diabetes	(Table	4).	In	both	models,	every	sd	in	depression	score	was	associated	with	a	significant	likelihood	of	type	2	diabetes	prevalence.	With	waist	circumference,	the	likelihood	was	estimated	to	be	40.0%	(p=0.027),	while	with	BMI	
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that	likelihood	was	42.5%	(p=0.020).		An	increase	in	sd	change	in	depression	score	was	also	associated	with	a	likelihood	of	diabetes	prevalence	(Table	4).	This	suggests	depressive	symptoms	are	more	predictive	of	diabetes	prevalence,	and	do	not	predict	type	2	diabetes	incidence	in	this	cohort.		
Table	4:	Relative	Risk	Ratio	(prevalent	versus	incident	diabetic,	n=1,651)			 Model	1	(Waist	Circumference)	 Model	2	(BMI)		 RRR	 Interval	 P-
Value	
RRR	 Interval	 P-
Value	
Depression	
Z-Score	
1.400	 (1.040,	
1.884)	
0.027	 1.425	 (1.058					
1.918)	
0.020	
Change	Z-
Score	
1.496	 (1.111,	
2.014)	
0.008	 1.502	 (1.116,	2.022)	 0.007	Age	2	3	 	0.475	0.751	 	(0.137,	1.647)	(0.213,	2.652)	 	0.240	0.656	 	0.480	0.786	 	(0.139,	1.662)	(0.223				2.775)	 	0.247	0.708	Education	2	3	 	0.995	0.930	 	(0.513,	1.930)	(0.439,	1.970)	 	0.988	0.850	 	0.997	0.934	 	(0.515,	1.932)	(0.441,	1.978)	 	0.776	0.858	Urbanicity	 1.024	 (1.002,	1.047)	 0.030	 1.026	 (1.004,	1.049)	 0.994	Assets	F1	 	0.994	 	(0.955,	1.035)	 	0.777	 	0.999	 	(0.959,	1.040)	 	0.953	Waist/BMI	 1.024	 (1.000,	1.047)	 0.050	 1.014	 (0.958,	1.073)	 0.634		
Discussion	That	high	depressive	symptoms	were	associated	with	increased	likelihood	of	type	2	diabetes	prevalence,	but	not	incidence,	is	inconsistent	with	previous	studies	of	high-income	country	populations	(3,	6–11).	The	findings	are	not	consistent	with	cohort	studies,	which	have	found	depression	to	be	positively	associated	with	increased	risk	of	incident	type	2	diabetes	(6–11).	Since	a	significant	association	was	found	between	depressive	symptoms	and	type	2	diabetes	prevalence,	our	data	suggests	reverse	causality-	that	type	2	diabetes	might	be	a	risk	factor	for	depressive	symptoms	in	middle-income	countries.	This	would	be	somewhat	consistent	with	the	bi-directional	model	supported	in	a	recent	meta-analysis,	which	looked	at	7	studies	that	investigated	the	relationship	from	this	direction.	However,	this	meta-analysis	found	only	modest	evidence	for	an	association,	while	our	study	suggests	the	association	to	be	more	considerable	in	the	Filipino	population	(3).	The	findings	are	
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also	consistent	with	a	more	recent	cohort	study,	which	found	that	while	the	relationship	between	depression	and	type	2	diabetes	is	bi-directional,	the	positive	association	between	treated	type	2	diabetes	and	depressive	symptoms	is	stronger	than	that	of	baseline	depressive	symptoms	and	incident	type	2	diabetes	(21).		That	type	2	diabetes	is	more	predictive	of	depressive	symptoms	in	the	Philippines	than	it	has	been	in	studies	of	high-income	countries	could	speak	to	the	negative	implications	and	fear	of	the	disease	in	the	developing	setting.	Such	fears	are	warranted-	diabetes	is	associated	with	more	severe	complications	and	higher	mortality	in	the	developing	setting,	where	it	is	less	often	diagnosed,	and	less	effectively	managed	(22–24).	Serious	complications	may	spur	from	the	lack	of	knowledge	about	the	disease	and	the	importance	of	treatment	(25).	But	this	lack	of	knowledge	may	also	lead	to	depressive	symptoms,	if	those	who	are	diagnosed	do	not	know	about	treatment	options	or	perceive	treatment	options	to	be	too	difficult	given	available	resources.	More	research	is	needed	to	discern	the	perception	and	knowledge	of	diabetes	in	the	Philippines.	In	settings	like	the	Philippines,	where	diabetes	health	outcomes	are	poorer,	the	illness	experience	may	play	a	larger	part	in	the	development	of	depressive	symptoms.	This	would	explain	why	depression	is	a	more	significant	predictor	of	type	2	diabetes	in	high-income	countries,	but	not	in	the	Philippines.		One	of	the	drawbacks	of	this	study	is	that	it	took	place	in	the	midst	of	the	survey’s	transition	from	fasting	blood	glucose	to	HbA1c	as	methods	of	diagnosing	type	2	diabetes.	As	a	result,	two	different	methods	of	diagnosis	were	used	in	2005	and	2012.	Using	two	different	metrics	to	diagnose	diabetes	in	each	respective	year	introduces	risk	of	some	misclassification.	However,	literature	supports	the	assumption	that	HbA1c	and	fasting	glucose	are	both	accurate	means	of	diagnosis.	A	cohort	study	assessing	cardio-metabolic	risk	in	China,	which	used	multiple	measurements	including	both	HbA1c	and	fasting	blood	glucose	to	diagnose	diabetes,	found	no	significant	difference	in	prevalence	based	on	either	method	(26).		This	suggests	that	misclassification	was	likely	too	minor	to	affect	the	results	from	our	model.		
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The	use	of	a	depression	measurement	instrument	altered	from	the	standard	CES-D	can	also	be	seen	as	a	weakness	of	this	study.	However,	the	research	team	stresses	that	the	changes	made	were	necessary	in	order	to	obtain	a	more	accurate	measurement	tool,	appropriate	for	Filipino	culture.	Furthermore,	previous	studies	have	run	promax	rotated	exploratory	factor	analyses	(EFA)	and	principal	component	analyses	(PCA)	of	the	2005	depressive	symptoms	scale	and	found	that	the	factors	emerged	were	comparable	to	those	found	by	Radloff’s	original	4-factor	solution	for	the	CES-D	(13).	These	findings	suggest	that	the	CLHNS	measure	can	be	interpreted	similarly	to	the	CES-D	in	western	populations	(13).	Another	possible	source	of	error	was	that	the	depression	scale	was	administered	via	in	person	interviews.	This	may	have	caused	a	response	bias	because	of	stigma	around	mental	health,	and	as	a	result	led	to	underreporting	of	depressive	symptoms.		This	study	is	one	of	the	first	to	look	at	the	relationship	between	depression	and	type	2	diabetes	incidence	in	a	middle-income	country-	making	the	findings	essential	to	establishing	a	more	comprehensive	picture	of	this	relationship,	inclusive	of	people	from	all	backgrounds	and	settings.		Aside	from	its	unique	population,	the	study	provides	many	advantages.	The	availability	of	robust	data	from	two	different	years	allowed	for	the	establishment	of	temporality	which	previous	cross-sectional	studies	were	unable	to	achieve.		Furthermore,	information	on	other	risk	factors	and	a	large	sample	size	allowed	for	a	more	complete	analysis	of	this	association	within	the	web	of	other	known	risk	factors	for	type	2	diabetes.	Diagnosis	of	type	2	diabetes	based	on	HbA1c	and	fasting	blood	glucose,	and	not	simply	self-report,	further	increased	the	accuracy	of	our	results.		Depression	and	diabetes	are	serious	problems	in	both	middle	and	low-income	countries.	Our	results	demonstrate	an	association	between	these	two	illnesses-	suggesting	that	more	public	health	efforts	should	treat	them	in	a	coordinated	fashion.	Recognizing	type	2	diabetes	as	a	risk	factor	for	depression	also	has	important	implications	for	early	diagnosis	and	prevention	of	mental	illness.	Mental	health	resources	are	sparse	in	the	Philippines,	posing	a	barrier	to	effective	treatment	and	screening.	According	the	WHO	2005	Mental	Health	Atlas,	the	Philippines	allocate	only	0.02%	of	the	total	health	budget	to	mental	health.	
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Furthermore,	there	are	0.9	psychologists	per	100,000	people,	and	0.4	psychiatrists	per	100,000	people	(27).	Our	study	findings	suggest	that	depression	may	be	a	sign	of	chronic	metabolic	disease,	and	that	with	increasing	diabetes	prevalence,	perhaps	an	increase	in	mental	health	treatment	resources	may	be	necessary.	Furthermore,	depression-diabetes	comorbidity	has	been	associated	with	increased	risk	of	other	diabetes	related	complications,	increased	rates	of	non-compliance,	increased	all-cause	mortality	and	increased	healthcare	expenditures	(28–30).	Treating	these	two	illnesses	in	a	coordinated	fashion	could	prove	effective	in	improving	the	health	of	such	patients.	Such	considerations	are	especially	relevant	in	the	context	of	middle-income	countries	like	the	Philippines,	where	funds	and	resources	are	already	sparse.	Coordinated	care	efforts	have	the	potential	to	reduce	healthcare	costs	in	these	settings.	In	conclusion,	this	cohort	study	suggests	that	depression	is	not	a	significant	risk	factor	for	type	2	diabetes	in	the	Philippines,	and	that	type	2	diabetes	is	more	likely	to	be	causing	depressive	symptoms.	More	research	is	needed	on	the	pathophysiological	mechanisms	that	could	explain	why	this	association	is	different	in	middle-income	settings.		Furthermore,	studies	that	incorporate	coordinated	care	treatments	of	depression	and	diabetes	have	yet	to	be	done.	This	study	was	the	first	to	look	at	depression	and	type	2	diabetes	in	the	context	of	a	middle-income	country:	more	studies	should	continue	to	investigate	this	association	in	diverse	settings	to	establish	universality.		Understanding	the	relationship	between	depression	and	type	2	diabetes	could	have	considerable	implications	for	the	prevention	of	both	of	these	debilitating	illnesses	in	countries	where	need	is	high	and	resources	are	low.			 	
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